{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:29:49Z","timestamp":1792081789378,"version":"4.4.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T00:00:00Z","timestamp":1700784000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006364","name":"French National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020147","name":"European Network for Rare Adult Solid Cancers","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020147","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.ejca.2023.113454","type":"journal-article","created":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T18:11:30Z","timestamp":1700763090000},"page":"113454","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Sclerosing Epithelioid Fibrosarcoma (SEF) versus Low Grade Fibromyxoid Sarcoma (LGFMS): Presentation and outcome in the nationwide NETSARC+ series of 330 patients over 13 years"],"prefix":"10.1016","volume":"196","author":[{"given":"JY","family":"Blay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Tlemsani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Toulmonde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Italiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Rios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Bompas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Valentin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Duffaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LR","family":"Le Nail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Firmin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Dubray-Longeras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ropars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Perrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Hervieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Lebbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Saada-Bouzid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Soibinet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Fiorenza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Bertucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Boudou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Vaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Bonvalot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Honor\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Marec-Berard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Minard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Cleirec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Biau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Meeus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Babinet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Dumaine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Carriere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Fau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Decanter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Gouin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Ngo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Le Loarer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Karanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Meurgey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Dufresne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Brahmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Chemin-Airiau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Ducimetiere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Penel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Le Cesne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ejca.2023.113454_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0246958","article-title":"Nationwide incidence of sarcomas and connective tissue tumors of intermediate malignancy over four years using an expert pathology review network","volume":"16","author":"de Pinieux","year":"2021","journal-title":"PLoS One"},{"issue":"15","key":"10.1016\/j.ejca.2023.113454_bib2","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1002\/cncr.33618","article-title":"Ultra-rare sarcomas: a consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities","volume":"127","author":"Stacchiotti","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2023.113454_bib3","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/00000478-199306000-00007","article-title":"Low-grade fibromyxoid sarcoma: a report of 12 cases","volume":"17","author":"Evans","year":"1993","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ejca.2023.113454_bib4","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1097\/00000478-200010000-00004","article-title":"Low-grade fibromyxoid sarcoma and hyalinizing spindle cell tumor with giant rosettes: a clinicopathologic study of 73 cases supporting their identity and assessing the impact of high-grade areas","volume":"24","author":"Folpe","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ejca.2023.113454_bib5","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.anndiagpath.2011.02.005","article-title":"Low-grade fibromyxoid sarcoma: a linicopathologic study of 18 cases, including histopathologic relationship with sclerosing epithelioid fibrosarcoma in a subset of cases","author":"Rekhi","year":"2011","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.ejca.2023.113454_bib6","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1097\/PAS.0b013e31822b3687","article-title":"Low-grade fibromyxoid sarcoma: a clinicopathologic study of 33 cases with long-term follow-up","volume":"35","author":"Evans","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ejca.2023.113454_bib7","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.anndiagpath.2017.04.001","article-title":"Low-grade fibromyxoid arcoma: clinical, morphologic and genetic features","volume":"28","author":"Mohamed","year":"2017","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.ejca.2023.113454_bib8","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/256280","article-title":"Low-grade fibromyxoid sarcoma: incidence, treatment strategy of metastases, and clinical significance of the FUS gene","volume":"2013","author":"Maretty-Nielsen","year":"2013","journal-title":"Sarcoma"},{"key":"10.1016\/j.ejca.2023.113454_bib9","first-page":"130","article-title":"Sclerosing epithelioid fibrosarcoma","volume":"vol 3","author":"Doyle","year":"2020"},{"key":"10.1016\/j.ejca.2023.113454_bib10","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1097\/00000478-199509000-00001","article-title":"Sclerosing epithelioid fibrosarcoma: a variant of fibrosarcoma simulating carcinoma","volume":"19","author":"Meis-Kindblom","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ejca.2023.113454_bib11","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/00000478-200106000-00001","article-title":"Sclerosing epithelioid fibrosarcoma: a study of 16 cases and confirmation of a clinicopathologically distinct tumor","volume":"25","author":"Antonescu","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ejca.2023.113454_bib12","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1097\/PAS.0b013e3180321959","article-title":"Translocation-positive low-grade fibromyxoid sarcoma: clinicopathologic and molecular analysis of a series expanding the morphologic spectrum and suggestingpotential relationship to sclerosing epithelioid fibrosarcoma: a study from the French sarcoma group","volume":"31","author":"Guillou","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ejca.2023.113454_bib13","first-page":"127","article-title":"Low grade fibromyxoid sarcoma","volume":"vol 3","author":"Doyle","year":"2020"},{"key":"10.1016\/j.ejca.2023.113454_bib14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s12105-007-0002-9","article-title":"Oral and maxillofacial sclerosing epithelioid fibrosarcoma: report of five cases","volume":"1","author":"Folk","year":"2007","journal-title":"Head Neck Pathol"},{"key":"10.1016\/j.ejca.2023.113454_bib15","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/apm.13157","article-title":"Sclerosing epithelioid fibrosarcoma: in-depth review of a genetically heterogeneous tumor","volume":"129","author":"Murshed","year":"2021","journal-title":"APMIS"},{"key":"10.1016\/j.ejca.2023.113454_bib16","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/PAS.0000000000001559","article-title":"Sclerosing epithelioid fibrosarcoma: a distinct sarcoma with aggressive features","volume":"45","author":"Warmke","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ejca.2023.113454_bib17","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.pathol.2022.10.005","article-title":"The clinicopathological spectrum of sclerosing epithelioid fibrosarcoma: report of an additional series with review of the literature","volume":"55","author":"Peng","year":"2023","journal-title":"Pathology"},{"key":"10.1016\/j.ejca.2023.113454_bib18","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1097\/PAS.0b013e3182562bf8","article-title":"MUC4 is a sensitive and extremely useful marker for sclerosing epithelioid fibrosarcoma: association with FUS gene rearrangement","volume":"36","author":"Doyle","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ejca.2023.113454_bib19","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1097\/00000478-200309000-00006","article-title":"Low-grade fibromyxoid sarcoma and hyalinizing spindle cell tumor with giant rosettes share a common t(7;16) (q34;p11) translocation","volume":"27","author":"Reid","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ejca.2023.113454_bib20","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/labinvest.3700230","article-title":"Clinicopathologic and molecular genetic characterization of low-grade fibromyxoid sarcoma, and cloning of a novel FUS\/CREB3L1 fusion gene","volume":"85","author":"Mertens","year":"2005","journal-title":"Lab Invest"},{"key":"10.1016\/j.ejca.2023.113454_bib21","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1097\/PAS.0b013e31827560f8","article-title":"A novel alternative molecular aberration of low-grade fibromyxoid sarcoma","volume":"37","author":"Lau","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ejca.2023.113454_bib22","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1097\/PAS.0000000000000158","article-title":"Recurrent EWSR1-CREB3L1 gene fusions in sclerosing epithelioid fibrosarcoma","volume":"38","author":"Arbajian","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ejca.2023.113454_bib23","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/modpathol.2011.214","article-title":"FUS rearrangements are rare in \u201cpure\u201d sclerosing epithelioid fibrosarcoma","volume":"25","author":"Wang","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ejca.2023.113454_bib24","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1097\/PAS.0b013e3182a05a6b","article-title":"EWSR1 rearrangements in sclerosing epithelioid fibrosarcoma","volume":"37","author":"Doyle","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ejca.2023.113454_bib25","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/gcc.22215","article-title":"A genetic dichotomy between pure sclerosing epithelioid fibrosarcoma (SEF) and hybrid SEF\/low-grade fibromyxoid sarcoma: a pathologic and molecular study of 18 cases","volume":"54","author":"Prieto-Granada","year":"2015","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.ejca.2023.113454_bib26","doi-asserted-by":"crossref","first-page":"7426","DOI":"10.1158\/1078-0432.CCR-17-1856","article-title":"In-depth genetic analysis of sclerosing epithelioid fibrosarcoma reveals recurrent genomic alterations and potential treatment targets","volume":"23","author":"Arbajian","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejca.2023.113454_bib27","doi-asserted-by":"crossref","first-page":"239","DOI":"10.21873\/invivo.11766","article-title":"Low-grade fibromyxoid sarcoma: treatment outcomes and efficacy of chemotherapy","volume":"34","author":"Chamberlain","year":"2020","journal-title":"In Vivo"},{"key":"10.1016\/j.ejca.2023.113454_bib28","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s12032-018-1192-6","article-title":"Clinical characteristics and efficacy of chemotherapy in sclerosing epithelioid fibrosarcoma","volume":"35","author":"Chew","year":"2018","journal-title":"Med Oncol"},{"key":"10.1016\/j.ejca.2023.113454_bib29","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1093\/annonc\/mdz170","article-title":"Surgery in reference centers improves survival of sarcoma patients: a nationwide study","volume":"30","author":"Blay","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2023.113454_bib30","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1093\/annonc\/mdx484","article-title":"Improved survival using specialized multidisciplinary board in sarcoma patients","volume":"28","author":"Blay","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2023.113454_bib31","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1002\/cncr.31176","article-title":"Presentation and outcome of frequent and rare sarcoma histologic subtypes: a study of 10,262 patients with localized visceral\/soft tissue sarcoma managed in reference centers","volume":"124","author":"Penel","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2023.113454_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2021.102312","article-title":"SELNET clinical practice guidelines for soft tissue sarcoma and GIST","volume":"102","author":"Blay","year":"2022","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.ejca.2023.113454_bib33","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.annonc.2021.07.006","article-title":"Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up\u2606","volume":"32","author":"Gronchi","year":"2021","journal-title":"Ann Oncol"},{"issue":"23","key":"10.1016\/j.ejca.2023.113454_bib34","first-page":"00135","article-title":"Why will there never be a randomized trial for NTRK-rearranged tumors","volume":"S0923\u20137534","author":"Penel","year":"2023","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2023.113454_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2023.101202","article-title":"Natural history and treatment efficacy in an ambispective case series of NTRK-rearranged mesenchymal tumors","volume":"8","author":"Dufresne","year":"2023","journal-title":"ESMO Open"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804923007566?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804923007566?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:43:05Z","timestamp":1760733785000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804923007566"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":35,"alternative-id":["S0959804923007566"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2023.113454","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sclerosing Epithelioid Fibrosarcoma (SEF) versus Low Grade Fibromyxoid Sarcoma (LGFMS): Presentation and outcome in the nationwide NETSARC+ series of 330 patients over 13 years","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2023.113454","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"113454"}}